Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Hurwitz, MD
Thomas Jefferson University and Hospitals
Principal Investigator - Ying Xiao, PhD
Bodine Center for Cancer Treatment at Thomas Jefferson University Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
70 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mcgill Cancer Centre at Mcgill University
Montreal, Quebec, Canada
- Arizona Oncology Services Foundation
Phoenix, Arizona, United States
- Auburn Radiation Oncology
Auburn, California, United States
- Radiation Oncology Centers - Cameron Park
Cameron Park, California, United States
- Mercy Cancer Center at Mercy San Juan Medical Center
Carmichael, California, United States
- Radiation Oncology Center - Roseville
Roseville, California, United States
- Mercy General Hospital
Sacramento, California, United States
- Radiological Associates of Sacramento Medical Group, Incorporated
Sacramento, California, United States
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- Solano Radiation Oncology Center
Vacaville, California, United States
- Urology Center of Colorado
Denver, Colorado, United States
- Poudre Valley Radiation Oncology
Fort Collins, Colorado, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Cancer Institute at St. John'S Hospital
Springfield, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Norton Suburban Hospital
Louisville, Kentucky, United States
- Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana, United States
- Mary Bird Perkins Cancer Center - Baton Rouge
Baton Rouge, Louisiana, United States
- Ccop - Ochsner
New Orleans, Louisiana, United States
- Mbccop - Lsu Health Sciences Center
New Orleans, Louisiana, United States
- Greenebaum Cancer Center at University of Maryland Medical Center
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Hudner Oncology Center at Saint Anne'S Hospital - Fall River
Fall River, Massachusetts, United States
- Josephine Ford Cancer Center at Henry Ford Hospital
Detroit, Michigan, United States
- Fairview Ridges Hospital
Burnsville, Minnesota, United States
- Mercy and Unity Cancer Center at Mercy Hospital
Coon Rapids, Minnesota, United States
- Fairview Southdale Hospital
Edina, Minnesota, United States
- Mercy and Unity Cancer Center at Unity Hospital
Fridley, Minnesota, United States
- Minnesota Oncology Hematology, Pa - Maplewood
Maplewood, Minnesota, United States
- Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
Minneapolis, Minnesota, United States
- Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center
Robbinsdale, Minnesota, United States
- Centracare Clinic - River Campus
Saint Cloud, Minnesota, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- United Hospital
Saint Paul, Minnesota, United States
- Ridgeview Medical Center
Waconia, Minnesota, United States
- Regional Cancer Center at Singing River Hospital
Pascagoula, Mississippi, United States
- Cancer Institute of Cape Girardeau, Llc
Cape Girardeau, Missouri, United States
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
St Louis, Missouri, United States
- Nevada Cancer Institute
Las Vegas, Nevada, United States
- Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton
Marlton, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2008
- Primary completion
- 31 Dec 2013
- Completion
- 14 May 2018
- Last update posted
- 24 Apr 2019
- Registered enrollment
- 80
- Registry id
- NCT00528866
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.